Stephen C. Glover
Co-Founder, Chairman, CEO & PresidentMr. Stephen C. Glover, also known as Steve & Steven, is an Independent Director of Oncolytics Biotech Inc. from June 1, 2026. He is Member of Advisory Board of PreveCeutical Medical Inc. from May 24, 2025. He serves as Chairman of the Board at Ambrx Biopharma Inc. since May 18, 2023. He has been a Director of Incon Co., Ltd. since December 2018. Mr. Glover is a Co-Founder, Director and Managing Principal for Asclepius Life Sciences Fund, LP. He is a Co-Founder of ZyVersa Therapeutics, Inc. (formerly Variant Pharmaceuticals, Inc.) and serves as its Chief Executive Officer, President and Chairman since December 12, 2022. Mr. Glover served as Chief Executive Officer and President of Old ZyVersa from March 2014 to December 2022, a member of the board of directors from March 2014 to September 2021 and Chairman from September 2021 to December 2022. Mr. Glover has business experience in biopharmaceuticals and life sciences. Mr. Glover was formerly the Co-Founder of Coherus Biosciences where he was focused on business strategy, partnerships, product development efforts and capitalization of the company. Mr. Glover has multifaceted experience in Fortune 100, start up and entrepreneurial environments. Mr. Glover was Co-Founder and served as the Chief Business Officer of Coherus Biosciences Inc. At Insmed, Mr. Glover was responsible for the creation of the biosimilar business unit and the divestiture of the business to Merck. At Andrx Mr. Glover was responsible for the strategy and operation of the Andrx Labs which developed and marketed products in metabolic diseases and Men's Health and Andrx Therapeutics which was focused on the development of new controlled release products and contract manufacturing. He served as the Chief Business Officer of InteKrin Therapeutics, Inc. He served as the President of Follow-on Biologics business of Insmed Incorporated since June 22, 2007 and served as President of Insmed Therapeutic Proteins, Inc., until March 31, 2009. He served as the Chief Business Officer of Insmed Incorporated from March 31, 2009 to December 2010. He served as Senior Vice President and General Manager of Andrx Laboratories and Andrx Therapeutics, both divisions of Andrx Corp. of Weston, Florida from 2004 to 2005. Mr. Glover founded Triangular Health Inc. and served as its Chief Executive Officer. He served as Director of Strategic Information Services of Amgen, Inc. from 1995 to 1998 and held key Executive positions at Hoffman-Laroche from 1984 to 1995, where he was responsible for significant sales increases and marketing programs for major pharmaceutical products. He held multiple sales, marketing and operational roles at IMS Health. He had been Director of PDS Biotechnology Corporation since April 2, 2019 until October 18, 2026 and had been its Chairman since July 2019 until October 18, 2026. Mr. Glover served as a Director of Auriga Laboratories Inc., from October 2006 to June 22, 2007. He as a BOD member of The Coulter Foundation as the University of Miami U Innovation Life Sciences Office and Asclepius Lifesciences. Mr. Glover received his B.S. degree in Marketing from Illinois State University in 1982.
Positions
- Company NameZyVersa Therapeutics, Inc.Stock CodeZVSAPositionCo-Founder, Chairman, CEO & President
